MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
NCT06198868 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2024-01-12
Summary
This is a prospective cohort study, which aims to evaluate the effectiveness and superiority of a novel minimal residual disease-guided prognosis monitoring and adjuvant treatment in stage IIA-IIIC non-small cell lung cancer.
Conditions
Interventions
- PROCEDURE
-
Operable
Enrolled patients capable of surgical treatment
Sponsors & Collaborators
-
Jiangsu Cancer Institute & Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-01
- Primary Completion
- 2026-02-01
- Completion
- 2027-02-01
Countries
- China
Study Locations
More Related Trials
-
Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer Diagnosis
NCT03830619 ·Status: COMPLETED
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC
NCT06503042 ·Status: NOT_YET_RECRUITING
-
Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 ·Status: UNKNOWN
-
PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
NCT05049837 ·Status: RECRUITING
-
Significance of MRD Monitoring in Patients With Potentially Resectable Stage III Non-small Cell Lung Cancer
NCT06081777 ·Status: RECRUITING
-
Application of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer
NCT07257458 ·Status: RECRUITING
-
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
NCT00899028 ·Status: COMPLETED
-
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
NCT05648370 ·Status: UNKNOWN
-
Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung Cancer
NCT05425134 ·Status: UNKNOWN
-
ctDNA as a Biomarker for Treatment in Advanced NSCLC
NCT05486988 ·Status: UNKNOWN
-
Monitoring the Changes of Tumor-related Biomarkers Before and After Pulmonary Nodule Biopsy.
NCT03397355 ·Status: UNKNOWN
-
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC
NCT05641870 ·Status: UNKNOWN
-
The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer
NCT06287320 ·Status: RECRUITING
-
Non-Invasive ctDNA Methylation Detection for Lung Nodule Patients
NCT03685669 ·Status: UNKNOWN
-
The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC
NCT06287593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Investigation on Predictive Molecular Markers of Efficacy for Front-line Immunochemotherapy in Advanced NSCLC
NCT04858828 ·Status: UNKNOWN
-
Evaluate the Auxiliary Diagnostic Value of Circulating Tumor Cells in Benign and Malignant Lung Nodules
NCT02653859 ·Status: UNKNOWN
-
MRD Monitoring in Lung Cancer After Resection
NCT04976296 ·Status: RECRUITING
-
Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients
NCT04229121 ·Status: UNKNOWN
-
Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
NCT07057102 ·Status: RECRUITING
-
Significance of MRD After Surgery in Driver Gene-positive and Driver Gene-negative Stage IB-IIA NSCLC
NCT05441566 ·Status: ENROLLING_BY_INVITATION
-
Comparison of Circulating Tumor DNA and Tumor Tissue DNA by Targeted Sequencing in Non-Small Cell Lung Cancer
NCT02645318 ·Status: COMPLETED
-
Survival Outcomes of Lung Cancer
NCT03647098 ·Status: RECRUITING
-
NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy
NCT04636047 ·Status: UNKNOWN